1 recruiting, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
Follow Malignant Pleural Mesotheliomas (Mpm): new trials by email Literature Review of Malignant Pleural Mesotheliomas (Mpm) trials Research Report on Malignant Pleural Mesotheliomas (Mpm)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors TLN-499, Venetoclax - Small Cell Lung Cancer ( SCLC ), Neuroendocrine Cancer | Phase 1 | Recruiting | Treeline Biosciences, Inc. | 120 | 2026-08-05 | 2026-10-01 |
| Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin Cytoreductive surgery, LMB-100, Immunohistochemical Assay for Mesothelin - Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe) | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2024-01-31 | 2024-02-02 |
Mesothelioma, Malignant (2) · Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Myeloproliferative Disorder, Chronic, with Eosinophilia (1) · Pleural Effusion, Malignant (1) · Recurrence (1) · Sarcoma, Synovial (1) · Small Cell Lung Carcinoma (1)
Adenoma (2) · Lung Diseases (2) · Lung Neoplasms (2) · Mesothelioma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Mesothelial (2) · Pleural Neoplasms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Adenocarcinoma (1) · Bronchial Neoplasms (1)
Cytoreduction Surgical Procedures (1) · LMB-100 (1) · venetoclax (1)
National Cancer Institute (NCI) (1) · Treeline Biosciences, Inc. (1)
Australia (1) · United States (1)
David S Schrump, M.D. (1) · Padma Yerramilli-Rao, MB BS, PhD (1)